Reuters reveals Illumina, Grail deal faces full-scale EU antitrust probe; market reacts
Reuters exclusively reported that U.S. life sciences company Illumina Inc’s proposed buy of cancer test maker Grail Inc faces a lengthy EU […] The post Reuters reveals Illumina, Grail deal faces full-scale EU antitrust probe; market reacts appeared first on Reuters News Agency.
admin
0
46
Reuters exclusively reported that U.S. life sciences company Illumina Inc’s proposed buy of cancer test maker Grail Inc faces a lengthy EU antitrust investigation if it does not offer hefty concessions this week. Illumina announced the $8 billion cash-and-stock deal for Grail last September, under which it will buy out investors, including Amazon.com Inc founder Jeff Bezos, to regain control of a company it spun out five years ago.
The post Reuters reveals Illumina, Grail deal faces full-scale EU antitrust probe; market reacts appeared first on Reuters News Agency.
